News
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)
"Dedos de Zinc, una posible solución a la enfermedad de Huntington" (CRG / Diario Médico)"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)
"Una inyección reduce la enfermedad de Huntington en ratones durante varios meses" (CRG / La Vanguardia.com)"The long-sought cure to Huntington's disease" (CRG / Cordis)
"The long-sought cure to Huntington's disease" (CRG / Cordis)
The Science to Business (S2B) Concept Challenge fosters again the CRG entrepreneurial spirit
The second edition of the Science to Business (S2B) Concept Challenge is open and ready to receive new ideas...
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
"The long-sought cure to Huntington's disease" (CRG / Research EU Results Magazine)
Challenges and rewards of building a biotech
12/09/2016 09:45 CHARLES DARWIN Keynote talk in the in the context of the 3rd CRG BioBusiness School."Challenges and rewards of building a biotech"Marc Martinell, CEO and Founder at Minoryx Therapeutics
Find it out next Friday, September 12 at 09h45 by joining the session.
Round-table: Why is this a good time to start your own company?
16/09/201610:00RAMON Y CAJAL
Find it out next Friday, September 16 at 10h00 by joining a round-table discussion with some of the most relevant members of our regional, as well as international ecosystem.
Expert panel
- Alexandre Casta (Investment Manager at Caixa Capital Risk)
- Oscar Flores (CEO and Founder of GenomCore)
- Luis Ruiz (CEO at Spherium Biomed)
- Leandro Vetcher (Associate Director of Business Development at Harvard OTD)
Chair
- Pablo Cironi (Head TBDO-CRG)
The round table is open to all the PRBB community, and it takes place in the context of the 3rd CRG BioBusiness School to be held at CRG from 12-16 September 2016. For more details please check the WebPage http://tbdo.crg.eu/entrepreneurs/entrepreneurs-...
Challenges and rewards of building a biotech
12/09/2016 09:45 CHARLES DARWIN Keynote talk in the in the context of the 3rd CRG BioBusiness School."Challenges and rewards of building a biotech"Marc Martinell, CEO and Founder at Minoryx Therapeutics
Find it out next Friday, September 12 at 09h45 by joining the session.
Round-table: Why is this a good time to start your own company?
16/09/201610:00RAMON Y CAJAL
Find it out next Friday, September 16 at 10h00 by joining a round-table discussion with some of the most relevant members of our regional, as well as international ecosystem.
Expert panel
- Alexandre Casta (Investment Manager at Caixa Capital Risk)
- Oscar Flores (CEO and Founder of GenomCore)
- Luis Ruiz (CEO at Spherium Biomed)
- Leandro Vetcher (Associate Director of Business Development at Harvard OTD)
Chair
- Pablo Cironi (Head TBDO-CRG)
The round table is open to all the PRBB community, and it takes place in the context of the 3rd CRG BioBusiness School to be held at CRG from 12-16 September 2016. For more details please check the WebPage http://tbdo.crg.eu/entrepreneurs/entrepreneurs-...
CRG Proof of Concept: Commercialization Gap Fund (CGF)
Deadline (Short Submission): 01/09/2016
Please send your application (max. 2 pages) under the following schemes:
- MIDI - Up to 6 months and 35 kEUR
- MAXI - Up to 12 months and 75 kEUR